Yousif Capital Management LLC Sells 3,448 Shares of Cardinal Health, Inc. $CAH

Yousif Capital Management LLC cut its position in shares of Cardinal Health, Inc. (NYSE:CAHFree Report) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 90,281 shares of the company’s stock after selling 3,448 shares during the period. Yousif Capital Management LLC’s holdings in Cardinal Health were worth $18,992,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Strategy Asset Managers LLC purchased a new stake in Cardinal Health during the 3rd quarter valued at about $775,000. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Cardinal Health by 15.3% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 37,833 shares of the company’s stock valued at $5,938,000 after buying an additional 5,030 shares during the period. Versor Investments LP acquired a new position in Cardinal Health in the 3rd quarter worth about $2,090,000. Atle Fund Management AB raised its holdings in Cardinal Health by 13.1% in the 3rd quarter. Atle Fund Management AB now owns 30,297 shares of the company’s stock worth $4,755,000 after purchasing an additional 3,500 shares during the period. Finally, Nordea Investment Management AB raised its holdings in Cardinal Health by 328.3% in the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after purchasing an additional 494,731 shares during the period. 87.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have commented on CAH shares. Robert W. Baird set a $252.00 target price on Cardinal Health in a report on Friday, February 6th. Argus upped their price target on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Barclays upped their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Leerink Partners restated an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Finally, Citigroup upgraded Cardinal Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $190.00 to $244.00 in a research report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $245.67.

Get Our Latest Stock Analysis on Cardinal Health

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $212.50 on Wednesday. The firm has a market capitalization of $50.01 billion, a price-to-earnings ratio of 30.58, a PEG ratio of 1.38 and a beta of 0.64. Cardinal Health, Inc. has a fifty-two week low of $121.17 and a fifty-two week high of $233.60. The stock has a 50 day moving average of $217.63 and a 200 day moving average of $199.80.

Cardinal Health (NYSE:CAHGet Free Report) last issued its quarterly earnings data on Thursday, February 5th. The company reported $2.63 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.32. The company had revenue of $65.63 billion during the quarter, compared to analyst estimates of $64.88 billion. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The firm’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.93 earnings per share. Analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be given a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, April 1st. Cardinal Health’s dividend payout ratio is presently 29.35%.

About Cardinal Health

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Articles

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.